YQ23 (New B Innovation Limited)

N/A

Report date: 2025/11/20 20:00:05

Base Information

Drug NameYQ23 (New B Innovation Limited)
Drug Alias NameYQ23YQ-23
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionOxygen carriersT lymphocytes modulators
TargetsNot applicable
Therapy Area/IndicationsSolid tumoursIschemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited KingdomHong Kong
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNew B Innovation
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNew Beta Innovation Ltd
Active IndicationsN/A
Inactive IndicationsSolid tumoursIschemia

Other Information

ATC CodeN/A
Related LinksN/A